Dr. Neil Shah

Contributions & Related Content

Videos

Future Directions in RCC: Triplets, Biomarkers, and Neoadjuvant Strategies

Expanding Adjuvant Therapy in RCC

Sequencing Lenvatinib-Based Therapy in Refractory RCC

Belzutifan Combinations and Second-Line Strategy in RCC

Frontline vs Second-Line RCC Strategy: Why Getting the First Choice Right Matters

Frontline RCC Treatment: Matching the Right Regimen to the Right Patient